GlassScriptPhysician profile
Luis Gonzalez-Fraga
NPI 1932186251
$4,835.26
in general payments reported to CMS, 2019-2025
53 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,311 · 2020: $852 · 2021: $1,376 · 2022: $786 · 2023: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $666.04 | 2019-2023 | Hizentra |
| Amarin Pharma, INC. | $453.75 | 2019-2021 | |
| Amgen INC. | $341.78 | 2019-2022 | |
| Novo Nordisk INC | $285.21 | 2019-2023 | Rybelsus, Ozempic |
| Pfizer INC. | $205.34 | 2019-2023 | |
| Esperion Therapeutics, INC. | $198.21 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $180.97 | 2019-2023 | Gammagard |
| Merck Sharp & Dohme LLC | $179.16 | 2019-2021 | |
| Glaxosmithkline, LLC. | $169.63 | 2019-2021 | |
| Abbvie INC. | $168.01 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $164.35 | 2019-2021 | |
| Allergan, INC. | $155.59 | 2019-2022 | |
| Lilly USA, LLC | $149.85 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $135.12 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $127.74 | 2019-2022 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Gonzalez-Fraga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.